Evidence map›Paper›PMID 29104875›Full record

ArticleJournal of immunology research2017

A Novel System for the Quantification of the ADCC Activity of Therapeutic Antibodies.

Christophe Lallemand, Feifei Liang, Flore Staub, Maud Simansour, Benoit Vallette, Lue Huang, Rosa Ferrando-Miguel, Michael G Tovey

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of immunology research, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Trial
  2. CD56bioRxiv : the preprint server for biology · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Christophe LallemandBiomonitor SAS, Villejuif Bio Park, 1 Mail du Professeur Georges Mathé, 94800 Villejuif, France.ORCID 0000-0001-5965-2482
Feifei LiangBiomonitor SAS, Villejuif Bio Park, 1 Mail du Professeur Georges Mathé, 94800 Villejuif, France.
Flore StaubBiomonitor SAS, Villejuif Bio Park, 1 Mail du Professeur Georges Mathé, 94800 Villejuif, France.
Maud SimansourBiomonitor SAS, Villejuif Bio Park, 1 Mail du Professeur Georges Mathé, 94800 Villejuif, France.
Benoit ValletteBiomonitor SAS, Villejuif Bio Park, 1 Mail du Professeur Georges Mathé, 94800 Villejuif, France.
Lue HuangBiomonitor SAS, Villejuif Bio Park, 1 Mail du Professeur Georges Mathé, 94800 Villejuif, France.
Rosa Ferrando-MiguelBiomonitor SAS, Villejuif Bio Park, 1 Mail du Professeur Georges Mathé, 94800 Villejuif, France.
Michael G ToveyBiomonitor SAS, Villejuif Bio Park, 1 Mail du Professeur Georges Mathé, 94800 Villejuif, France.ORCID 0000-0002-3058-0494
Laboratoire d'études sur les monothéismes · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Novel ADCC effector cells expressing the V-variant or F-variant of Fc

Indexed as

Antibody-Dependent Cell CytotoxicityAntigens, CD20CetuximabCrohn DiseaseErb-b2 Receptor Tyrosine KinasesErbB ReceptorsEtanerceptGenes, ReporterHEK293 CellsHumansImmunologic TechniquesInfliximabJurkat CellsNFATC Transcription FactorsReceptors, IgGRituximabAntigens, CD20CetuximabEGFR protein, humanERBB2 protein, humanErb-b2 Receptor Tyrosine KinasesErbB ReceptorsEtanerceptFCGR3A protein, humanInfliximabNFATC Transcription FactorsReceptors, IgGRituximabTrastuzumabTumor Necrosis Factor-alpha

Identifiers

PMID29104875
PMCPMC5635472
OpenAlexW2758946207

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.